TRPV1 in dorsal root ganglion contributed to bone cancer pain
Authors:
Open Access
- 9 November 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 3, 1022022
Abstract
Tumor growth in situ or bone metastases in cancer patients all can induce bone cancer pain. It is frequently occurred in patients with breast, prostate, and lung cancer. Because of the lack of effective treatment, bone cancer pain causes depression, anxiety, fatigue, and sleep disturbances in cancer patients, disrupts the daily quality of life, and results in huge economic and psychological burden. Over the past years, transient receptor potential channels (TRPs), especially TRP vanilloid 1 (TRPV1) in dorsal root ganglion (DRG), have been considered to be involved in bone cancer pain. The characteristic of TRPV1 had been well studied. The mechanisms under TRPV1 regulation in DRG with bone cancer pain are complex, including inflammatory mediators, endogenous formaldehyde, and other mechanisms. In the present review, we summarize the role and potential mechanism of TRPV1 in DRG in bone cancer pain. As the primary sensory neurons, targeting the TRPV1 channel in DRG, might have fewer side effects than in central. We hope systematically understand of TRPV1 modulation in DRG will bring more effective strategy.Keywords
This publication has 37 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Enhanced Excitability of Small Dorsal Root Ganglion Neurons in Rats with Bone Cancer PainMolecular Pain, 2012
- In Vitro Sarcoma Cells Release a Lipophilic Substance That Activates the Pain Transduction System via TRPV1Annals of Surgical Oncology, 2010
- Tumor Tissue-Derived Formaldehyde and Acidic Microenvironment Synergistically Induce Bone Cancer PainPLOS ONE, 2010
- Reduction of bone cancer pain by CB1 activation and TRPV1 inhibitionJournal of Anesthesia, 2010
- Involvement of Lysophosphatidic Acid in Bone Cancer Pain by Potentiation of TRPV1 via PKCe Pathway in Dorsal Root Ganglion NeuronsMolecular Pain, 2010
- Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermiaPain, 2009
- Endogenous Tumor Necrosis Factor α (TNFα) Requires TNF Receptor Type 2 to Generate Heat Hyperalgesia in a Mouse Cancer ModelThe Journal of Neuroscience, 2008
- TRP channels in cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing StimuliNeuron, 1998